questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of trends in the number of patients with metabolic dysfunction–associated steatohepatitis on the NHS in (a) Nottinghamshire and (b) Mansfield con
answerText: Data on hospital admission rates for metabolic dysfunction-associated steatotic liver disease (MASLD), of which metabolic dysfunction–associated steatohepatitis is a stage in some cases, is available at the Department’s Fingertips website, and can be used...
heading: Liver Diseases: Nottinghamshire